CURX
Curanex Pharmaceuticals Inc Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Curanex Pharmaceuticals (CURX) Stock: Buy, Sell, or Hold?
$5.63
-0.46 (-7.64%)
âŧ
5d:
-3.02%
30d:
+15.27%
90d:
+2388.94%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (29%)
Quality Score
29/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$4.69 â $5.74
Position: SLIGHTLY HIGH
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$4.38 / $6.31
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: CURX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When CURX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CURX is currently trading at $5.62, which is considered slightly high relative to its 30-day fair value range of $4.69 to $5.74.
Technical Outlook: Technically, CURX is in a strong uptrend. Immediate support is located at $4.38, while resistance sits at $6.31. Short-term momentum is weak, with the stock down 7.6% recently.
Market Sentiment: CURX scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CURX is in a strong uptrend. Immediate support is located at $4.38, while resistance sits at $6.31. Short-term momentum is weak, with the stock down 7.6% recently.
Market Sentiment: CURX scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$4.69 -
$5.74
Company Quality Score
29/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
29.4%
Trading Range & Key Levels
30-Day Trading Range
$4.69 -
$5.74
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$4.38
Resistance Level
$6.31
Current Trend
Strong Uptrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.6%)
- WARNING: Composite score 29/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Share CURX Analysis
Share this live CURX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CURX)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 5, 2026
Daily AI digest
AI Retail Discussion Summary:
SCAG announced a strategic cooperation agreement with China Huaye Group, potentially increasing their market presence in China.
Key Retail Themes:
China expansion
Strategic partnership
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 12:06 PM ET
Data refreshes hourly during market hours. Next update: 1:06 PM
Data refreshes hourly during market hours. Next update: 1:06 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CURX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 49 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 34 SELL |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 32 SELL |
|
ZYME
Zymeworks Inc. Common StâĻ |
STRONG BUY
14 analysts |
$42 | 42 HOLD |
|
ARWR
Arrowhead PharmaceuticalâĻ |
STRONG BUY
15 analysts |
$108 | 43 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CURX Research Pages